You are here

Article Text

Article menu
Download PDFPDF
Therapeutics
Orlistat with diet was effective and safe for weight loss and coronary risk reduction in obesity

https://doi.org/10.1136/ebm.6.2.54

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Source of funding: Roche AB, Stockholm, Sweden.

    • For correspondence: Dr F Lindgärde, Department of Vascular Disease, Malmö University Hospital, University of Lund, 20502 Malmö, Sweden. Fax + 46 4019 4617.

    • ↵* See glossary.